StockNews.com Begins Coverage on Galectin Therapeutics (NASDAQ:GALT)
StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a report on Tuesday, August […]
More Stories
Hobbs Group Advisors LLC Sells 620 Shares of iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV)
Hobbs Group Advisors LLC lessened its holdings in shares of iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV – Free Report)...
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Hobbs Group Advisors LLC
Hobbs Group Advisors LLC grew its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.1% in the third quarter,...
Geode Capital Management LLC Has $1.41 Billion Stake in CSX Co. (NASDAQ:CSX)
Geode Capital Management LLC boosted its holdings in shares of CSX Co. (NASDAQ:CSX – Free Report) by 0.5% during the...
Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Coldstream Capital Management Inc.
Coldstream Capital Management Inc. boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 254.2% during...
Cognyte Software (NASDAQ:CGNT) Updates FY 2025 Earnings Guidance
Cognyte Software (NASDAQ:CGNT – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The...
Teachers Retirement System of The State of Kentucky Purchases 33,147 Shares of Jabil Inc. (NYSE:JBL)
Teachers Retirement System of The State of Kentucky lifted its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 9.9%...